ICON PLC (ICLR)
IE0005711209 - Common Stock
ICLR Stock Earnings: Icon Beats EPS, Meets Revenue for Q1 2024
ICLR stock results show that Icon beat analyst estimates for earnings per share but met on revenue for the first quarter of 2024.
ICLR Stock Earnings: Icon Beats EPS, Meets Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Icon (NASDAQ:ICLR) just reported results for the first quarter of 2024.Icon rep...
ICON Reports First Quarter 2024 Results
Icon Becomes Oversold (ICLR)
ICON Announces CFO Transition
ICON plc Schedules First Quarter 2024 Earnings Conference Call
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Agilent Technologies Stock Getting Closer To Key Technical Benchmark
Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.
Stocks to Watch: 3 Up-and-Coming Companies Catering to Next-Gen Consumers
Discover three promising stocks that are positioned to win over the rising wave of next generation consumers.
ICON plc to Present at Upcoming Investor Conferences
Icon Non-GAAP EPS of $3.46 beats by $0.01, revenue of $2.07B misses by $20M (NASDAQ:ICLR)
Icon (ICLR) reports Q4 non-GAAP EPS beating estimates by $0.01, but revenue misses by $20M.
ICON Reports Fourth Quarter and Full Year 2023 Results
First Week of October 18th Options Trading For Icon (ICLR)
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
Biogen stock slips as UBS downgrades (NASDAQ:BIIB)
Biogen (BIIB) stock traded lower after UBS downgraded it citing slower uptake for its Alzheimer's treatment Leqembi marketed with Eisai (ESALF) (ESAIY). Read more here.
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
First Week of ICLR February 16th Options Trading
Oversold Conditions For Icon
Icon Moves Up In Market Cap Rank, Passing Alexandria Real Estate Equities
ICON Issues Financial Guidance for Full Year 2024
Interesting ICLR Put And Call Options For July 19th
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
A red-hot product or service right now doesn't mean much if demand for it isn't going to last.
ICON plc to Present at Upcoming Investor Conferences
(NASDAQ:ICLR)
Icon reports third quarter 2023 results with GAAP EPS missing estimates by $0.01.
ICON Reports Third Quarter 2023 Results